Track topics on Twitter Track topics that are important to you
Johnson Johnson Vision Gets Approval TECNIS Toric Piece PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Johnson Johnson Vision Gets Approval TECNIS Toric Piece articles that have been published worldwide.
We have published hundreds of Johnson Johnson Vision Gets Approval TECNIS Toric Piece news stories on BioPortfolio along with dozens of Johnson Johnson Vision Gets Approval TECNIS Toric Piece Clinical Trials and PubMed Articles about Johnson Johnson Vision Gets Approval TECNIS Toric Piece for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Johnson Johnson Vision Gets Approval TECNIS Toric Piece Companies in our database. You can also find out about relevant Johnson Johnson Vision Gets Approval TECNIS Toric Piece Drugs and Medications on this site too.
In the present study, we aimed to evaluate the early postoperative rotational stability of TECNIS toric intraocular lens (IOL) and analyse its correlation with preoperative and intraoperative parameters.
To assess corneal morphologic changes and surgically induced astigmatism (SIA) following clear corneal incisions (CCIs) created manually or with the Catalys femtosecond laser (Johnson & Johnson Vision, Santa Ana, CA).
Epidermal necrolysis (EN), the spectrum including Stevens-Johnson syndrome (SJS, detached-detachable body surface area [BSA]
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but severe adverse drug reactions with high mortality. The use of corticosteroids and the management of complications (e.g. infection) in SJS/TEN remains controversial.
Stevens-Johnson syndrome and toxic epidermal necrolysis represent important sources of potential mortality and morbidity in children. There is a need for more clinical data in this population to determine whether specific treatments preferentially improve outcomes.
The predictors of readmission in Stevens-Johnson Syndrome/Toxic epidermal necrolysis (SJS/TEN) have not been characterized.
This study aimed to identify the clinical clues in patients with chronic cicatrising conjunctivitis (CCC), that were suggestive of Stevens-Johnson syndrome (SJS) as the aetiology.
Ethnic differences exist in relation to culprit drugs for Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). We wanted to determine culprit drugs for SJS and TEN in Korean population.
To characterize the topography patterns and quantify corneal higher-order aberrations (HOAs) in the chronic phase of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN).
To investigate the details of the long-term progression of ocular surface cicatrization in eyes with ocular sequelae caused by Stevens-Johnson syndrome (SJS)/toxic epidermal necrosis (TEN).
In Sub-Saharan Africa, manifestations of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are commonly seen in human immunodeficiency virus-infected patients receiving nevirapine-based antiretroviral therapy and/or cotrimoxazole. These patients often face severe ocular complications that lead to moderate to severe visual impairment or blindness.
To describe the long-term impact of a treatment protocol for ocular involvement in acute Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN), including focused ocular examination and pathology-appropriate use of lubrication, topical corticosteroids, topical antibiotics, and amniotic membrane transplantation.
The relation between visual processing speed (critical flicker fusion thresholds [CFF] and psychomotor reaction time) and higher-level cognitive function was assessed using a cross-sectional sample ( = 51) of 7 to 13-year-old preadolescent children. Data on visual processing speed (CFF and psychomotor reaction time) and cognitive function (Woodcock-Johnson III Tests of Cognitive Abilities) were collected. Woodcock-Johnson III composite standard scores (brief intellectual ability [BIA], cognitive efficie...
Cicatrizing conjunctivitis is the final consequence of several diseases. The most severe among them are cicatricial pemphigoid and chronic Stevens-Johnson syndrome. Systemic immunosuppressive drugs and steroids are usually an effective approach to these diseases. However, a few patients follow a recalcitrant course unremitting to usual therapy. We describe the treatment with rituximab of seven patients with cicatricial pemphigoid and two with chronic Stevens-Johnson syndrome. Eight of them also received gam...
Rivaroxaban (Xarelto; Johnson & Johnson Services, Inc) is a direct oral anticoagulant (DOAC) that works by directly inhibiting the active site of factor Xa (FXa). Rivaroxaban is metabolized and cleared via the kidney and liver. The results of various studies have shown that patients with severe renal impairment should receive reduced dosages of rivaroxaban or another anticoagulant due to impaired clearance. Although it is not required, monitoring rivaroxaban is useful in some conditions; however, the assays...
An 84-year-old woman had a subarachnoid hemorrhage caused by rupture of a 3.7 mm × 3.5 mm broad-necked aneurysm on the origin of the left posterior inferior cerebellar artery. We decided to perform the double microcatheter technique (DMT) for coil embolization. However, despite the use of various techniques, placement of 6 Fr. guiding catheter within the left vertebral artery failed because the patient had very tortuous and calcified vessels from the femoral artery to VA. As a result, we changed the plan t...
: Stevens-Johnson syndrome (SJS) and its severe phenotype, toxic epidermal necrolysis (TEN), are acute inflammatory vesiculobullous reactions of the skin, the mucosa of the ocular surface, the oral cavity, and the genitals. Approximately 50% of SJS/TEN patients diagnosed by dermatologists and in burn units suffer from severe ocular complications (SOC) such as severe conjunctivitis with pseudomembrane and ocular surface epithelial defects in the acute stage.: Earlier studies on patients with Stevens-Johnson ...